The Impact of Direct-Acting Antivirals in the Hepatitis C-Sustained Viral Response in Human Immunodeficiency Virus-Infected Patients With Ongoing Barriers to Care

Background. Access to hepatitis C virus (HCV) medications for human immunodeficiency virus (HIV)-infected patients with ongoing barriers to care is restricted by healthcare payers in the absence of HCV treatment outcomes data in the era of direct-acting antivirals (DAA). Methods. Retrospective analy...

Descripción completa

Detalles Bibliográficos
Autores principales: Cachay, Edward R., Wyles, David, Hill, Lucas, Ballard, Craig, Torriani, Francesca, Colwell, Bradford, Kuo, Alexander, Schooley, Robert, Mathews, Christopher W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Major Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4683297/
https://www.ncbi.nlm.nih.gov/pubmed/26697509
http://dx.doi.org/10.1093/ofid/ofv168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4683297/
https://www.ncbi.nlm.nih.gov/pubmed/26697509
http://dx.doi.org/10.1093/ofid/ofv168

Ejemplares similares